IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML

Weill Cornell Medical College, New York Presbyterian Hospital (110), New York

Winship Cancer Institute of Emory University (105), Atlanta

Cleveland Clinic, Taussig Cancer Institute (111), Cleveland

The University of Chicago (113), Chicago

University of Texas Southwestern, Simmons Comprehensive Cancer Center (104), Dallas

MD Anderson Cancer Center (101), Houston

University of Colorado, Anschutz Medical Campus (103), Aurora

UCLA, Medical Center Division of Hematology/Oncology (119), Los Angeles

City of Hope (106), Duarte

University of California, Irvine (107), Irvine

University of California, San Francisco (118), San Francisco

Stanford University (114), Palo Alto

University California, Davis (117), Davis

Oregon Health and Science University, Center for Hematologic Malignancies (116), Portland